![Paolo Tarantino: More than 25 ASCO24 oral presentations by Dana-Farber Cancer Institute researchers](https://oncodaily.com/pub/uploads/2024/05/paolik-e1719386330584.png)
Photo from Paolo Tarantino/X
May 31, 2024, 15:41
Paolo Tarantino: More than 25 ASCO24 oral presentations by Dana-Farber Cancer Institute researchers
Paolo Tarantino shared a post by Dana-Farber Cancer Institute on X:
“More than 25 ASCO24 oral presentations by Dana-Farber Cancer Institute researchers, including Antonio Giordano presenting on the Nectin4 ADC enfortumab vedotin for metastatic breast cancer and Ana Garrido-Castro presenting the first randomized Topo1 ADC-IO trial in breast oncology!” .
Quoting Dana-Farber Cancer Institute’s post:
“Heading to ASCO24? There are more than 25 oral presentations that are Dana-Farber researcher lead. Check out the list and follow Dana Farber News for full conference coverage.”
Source: Paolo Tarantino/X and Dana-Farber Cancer Institute/X
Aug 13, 2024, 14:45